Gainers
- Sunedison Semiconductor Ltd (NASDAQ: SEMI) rose 42.5 percent to $11.80 in pre-market trading as GlobalWafers Co., Ltd. agreed to buy SunEdison Semiconductor for US$12.00 per share in cash. Citigroup upgraded SunEdison Semiconductor from Sell to Neutral.
- Cobalt International Energy, Inc. (NYSE: CIE) shares rose 23.8 percent to $1.30 in pre-market trading after gaining 5.99 percent on Wednesday.
- Raptor Pharmaceutical Corp. (NASDAQ: RPTP) shares rose 15.8 percent to $7.99 in pre-market trading. Retrophin Inc (NASDAQ: RTRX) is considering an acquisition of Raptor Pharmaceutical, according to Bloomberg.
- Immunomedics, Inc. (NASDAQ: IMMU) shares rose 9.4 percent to $3.14 in pre-market trading after the company reported that its preclinical study on enhancing IMMU-132 activity in SN-38-resistant cancer cells increased the median survival of mice.
- SCYNEXIS Inc (NASDAQ: SCYX) rose 8.9 percent to $2.82 in pre-market trading after surging 25.73 percent on Wednesday.
- NetApp Inc. (NASDAQ: NTAP) rose 8.3 percent to $31.25 in pre-market trading as the company reported better-than-expected earnings for its fiscal first quarter on Wednesday.
- Canadian Solar Inc. (NASDAQ: CSIQ) rose 8.1 percent to $13.20 in the pre-market trading session. Canadian Solar reported Q2 earnings of $0.68 per share on revenue of $805.9 million.
- Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) rose 6.8 percent to $6.77. Cantor Fitzgerald initiated coverage on Arrowhead Pharmaceuticals with a Buy rating.
- Staples, Inc. (NASDAQ: SPLS) rose 6.3 percent to $9.22 in pre-market trading after dropping 7.07 percent on Wednesday.
- L Brands Inc (NYSE: LB) rose 4 percent to $77.00 in pre-market trading as the company posted upbeat earnings for its second quarter after market close on Wednesday.
- Wal-Mart Stores, Inc. (NYSE: WMT) rose 3.4 percent to $75.40 in pre-market trading as the company reported better-than-expected EPS and revenue for the second quarter. The company updated its EPS forecast for the full year.
- YY Inc (ADR) (NASDAQ: YY) rose 3.3 percent to $50.70 in the pre-market trading session. YY reported a Q2 profit of $51.7 million and reported the resignation of Chairman Mr. Jun Lei.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- Cerulean Pharma Inc (NASDAQ: CERU) fell 61.3 percent to $1.06 in pre-market trading after the company reported failed CRLX101/Avastin trial results. Leerink Swann, Janney Capital and JMP Securities downgraded the stock following the news.
- Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares fell 15.6 percent to $19.99 in pre-market trading as the company reported that it has received a CRL from the FDA for Biologics License Application for AndexXa.
- Juniper Pharmaceuticals Inc (NASDAQ: JNP) shares dropped 15.3 percent to $6.03 in pre-market trading. Juniper Pharma reported that its Phase 2b trial of COL-1077 lidocaine vaginal gel did not meet primary and secondary endpoints.
- Aerie Pharmaceuticals Inc (NASDAQ: AERI) shares fell 14.8 percent to $16 in pre-market trading.
- Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares fell 14 percent to $10.07 in pre-market trading. OncoMed priced an offering of 5.5 million shares at $10 per share.
- Momo Inc (ADR) (NASDAQ: MOMO) fell 4.5 percent to $14.88 in pre-market trading. Momo reported Q2 adjusted earnings of $0.03 per ADS and announced that the Buyer Group will withdraw the non-binding go-private offer.
- Agilent Technologies Inc (NYSE: A) shares fell 4 percent to $46.49 in the pre-market trading session. Agilent posted better-than-expected earnings for its third quarter. However, the company reported downbeat quarterly sales and issued a weak FY16 guidance.
- Twitter Inc (NYSE: TWTR) shares fell 2.5 percent to $19.67 in pre-market trading. Evercore ISI Group downgraded Twitter from Hold to Sell and lowered the price target from $18.00 to $17.00.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
